Cargando…
Progress towards a public chemogenomic set for protein kinases and a call for contributions
Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic s...
Autores principales: | Drewry, David H., Wells, Carrow I., Andrews, David M., Angell, Richard, Al-Ali, Hassan, Axtman, Alison D., Capuzzi, Stephen J., Elkins, Jonathan M., Ettmayer, Peter, Frederiksen, Mathias, Gileadi, Opher, Gray, Nathanael, Hooper, Alice, Knapp, Stefan, Laufer, Stefan, Luecking, Ulrich, Michaelides, Michael, Müller, Susanne, Muratov, Eugene, Denny, R. Aldrin, Saikatendu, Kumar S., Treiber, Daniel K., Zuercher, William J., Willson, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540273/ https://www.ncbi.nlm.nih.gov/pubmed/28767711 http://dx.doi.org/10.1371/journal.pone.0181585 |
Ejemplares similares
-
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification
por: Wells, Carrow I., et al.
Publicado: (2021) -
An open source plant kinase chemogenomics set
por: Ercoli, Maria Florencia, et al.
Publicado: (2022) -
WNT Activates the AAK1 Kinase to Promote Clathrin-Mediated Endocytosis of LRP6 and Establish a Negative Feedback Loop
por: Agajanian, Megan J., et al.
Publicado: (2019) -
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor
por: Tamir, Tigist Y., et al.
Publicado: (2020) -
Seeding Collaborations to Advance Kinase Science with the GSK Published Kinase Inhibitor Set (PKIS)
por: Drewry, David H., et al.
Publicado: (2014)